JP2013538355A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013538355A5 JP2013538355A5 JP2013528815A JP2013528815A JP2013538355A5 JP 2013538355 A5 JP2013538355 A5 JP 2013538355A5 JP 2013528815 A JP2013528815 A JP 2013528815A JP 2013528815 A JP2013528815 A JP 2013528815A JP 2013538355 A5 JP2013538355 A5 JP 2013538355A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- fibrinogen
- fibrin
- thrombin
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000000523 sample Substances 0.000 claims 37
- 238000000034 method Methods 0.000 claims 34
- 108010049003 Fibrinogen Proteins 0.000 claims 22
- 102000008946 Fibrinogen Human genes 0.000 claims 22
- 229940012952 fibrinogen Drugs 0.000 claims 22
- 102000009123 Fibrin Human genes 0.000 claims 19
- 108010073385 Fibrin Proteins 0.000 claims 19
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 19
- 229950003499 fibrin Drugs 0.000 claims 19
- 239000002245 particle Substances 0.000 claims 18
- 108090000190 Thrombin Proteins 0.000 claims 8
- 210000004369 blood Anatomy 0.000 claims 8
- 239000008280 blood Substances 0.000 claims 8
- 229960004072 thrombin Drugs 0.000 claims 6
- 239000000126 substance Substances 0.000 claims 5
- 239000006249 magnetic particle Substances 0.000 claims 4
- 101000772006 Bombus ignitus Venom serine protease Bi-VSP Proteins 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108010071289 Factor XIII Proteins 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 239000013592 cell lysate Substances 0.000 claims 2
- 239000002738 chelating agent Substances 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 2
- 230000002950 deficient Effects 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- 229940012444 factor xiii Drugs 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 claims 1
- 108091023037 Aptamer Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 101710128530 Fibrinogen-binding protein Proteins 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 210000001772 blood platelet Anatomy 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000012459 cleaning agent Substances 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 230000001461 cytolytic effect Effects 0.000 claims 1
- 102000025748 fibrinogen binding proteins Human genes 0.000 claims 1
- 239000003527 fibrinolytic agent Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000001293 nucleolytic effect Effects 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000004623 platelet-rich plasma Anatomy 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH01478/10 | 2010-09-15 | ||
| CH14782010 | 2010-09-15 | ||
| CH20412010 | 2010-12-07 | ||
| CH02041/10 | 2010-12-07 | ||
| CH01207/11 | 2011-07-20 | ||
| CH12072011 | 2011-07-20 | ||
| PCT/IB2011/054035 WO2012035508A2 (en) | 2010-09-15 | 2011-09-15 | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013538355A JP2013538355A (ja) | 2013-10-10 |
| JP2013538355A5 true JP2013538355A5 (enExample) | 2015-08-06 |
| JP5999776B2 JP5999776B2 (ja) | 2016-09-28 |
Family
ID=45044632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013528815A Active JP5999776B2 (ja) | 2010-09-15 | 2011-09-15 | 血液成分を含むフィブリノゲン含有サンプルからターゲット分子又は粒子を分離する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US9689881B2 (enExample) |
| EP (2) | EP2616550B1 (enExample) |
| JP (1) | JP5999776B2 (enExample) |
| KR (1) | KR101948944B1 (enExample) |
| CN (2) | CN107389932B (enExample) |
| AU (2) | AU2011303467C1 (enExample) |
| CA (1) | CA2811493C (enExample) |
| CY (1) | CY1122166T1 (enExample) |
| DK (2) | DK2616550T3 (enExample) |
| ES (2) | ES2751660T3 (enExample) |
| HR (1) | HRP20191785T1 (enExample) |
| HU (2) | HUE028915T2 (enExample) |
| LT (1) | LT3067431T (enExample) |
| PL (2) | PL2616550T3 (enExample) |
| PT (1) | PT3067431T (enExample) |
| SI (1) | SI3067431T1 (enExample) |
| WO (1) | WO2012035508A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9689881B2 (en) | 2010-09-15 | 2017-06-27 | Spinomix S.A. | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| CN103702674B (zh) | 2011-06-27 | 2018-05-29 | 爱默蕾大学 | 血小板裂解物的组合物、用途和制备 |
| EP2979093B1 (en) * | 2013-03-29 | 2019-10-23 | Siemens Healthcare Diagnostics Inc. | Rare cell concentration |
| ES2740838T3 (es) * | 2014-06-01 | 2020-02-06 | Debiopharm Int Sa | Dispositivo de recolección y procesamiento de muestras |
| US12397302B2 (en) | 2015-11-30 | 2025-08-26 | Dh Technologies Development Pte. Ltd. | Electromagnetic assemblies for processing fluids |
| WO2017156375A1 (en) | 2016-03-10 | 2017-09-14 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
| WO2017156379A2 (en) | 2016-03-10 | 2017-09-14 | Arthrex, Inc. | Systems and methods for preparing protein enhanced serums |
| KR20210052389A (ko) | 2018-08-27 | 2021-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 다운스트림 정제에서의 라만 분광법의 사용 |
| JP7298449B2 (ja) * | 2019-11-14 | 2023-06-27 | 株式会社島津製作所 | 血液凝固分析装置、及び分注ノズルの洗浄方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1035260A (en) * | 1974-08-12 | 1978-07-25 | Baxter Travenol Laboratories | Collection and processing tube |
| FR2625321B1 (fr) * | 1987-12-24 | 1992-10-02 | Pasteur Institut | Reactif pour le diagnostic de staphylococcus aureus par agglutination |
| DE58902472D1 (de) * | 1988-01-05 | 1992-11-26 | Linhart Axel | Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut. |
| DE3803463A1 (de) * | 1988-02-05 | 1989-08-17 | Linhart Axel | Semiquantitativer kalzium-schnelltest |
| US5691160A (en) * | 1992-08-14 | 1997-11-25 | Biogen, Inc. | Effects of actin filaments of fibrin clot structure and lysis |
| EP0587398B1 (en) * | 1992-09-09 | 1998-01-14 | Tokuyama Corporation | Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof |
| JP3292760B2 (ja) * | 1993-04-22 | 2002-06-17 | テルモ株式会社 | 採血管およびその製造方法 |
| US5670329A (en) * | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
| WO1995015397A1 (en) | 1993-12-03 | 1995-06-08 | Dorn Gordon L | Method for improving quantitative recovery of microorganisms fro m specimens containing blood components |
| DE19602673A1 (de) * | 1996-01-25 | 1997-08-07 | Pereg Gmbh | Synthetische Testanschmutzung |
| US6121232A (en) * | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| US6680195B1 (en) * | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| JP2000262499A (ja) * | 2000-01-01 | 2000-09-26 | Terumo Corp | 採血管 |
| US6686204B2 (en) * | 2001-08-27 | 2004-02-03 | Becton, Dickinson & Company | Collection device |
| WO2003028743A1 (en) * | 2001-10-03 | 2003-04-10 | Woolverton Christopher J | Storage-stable fibrinogen solutions |
| JP4718833B2 (ja) * | 2002-05-01 | 2011-07-06 | シナプス ベスローテン フェンノートシャップ | 複合生物媒体における、一時的なタンパク質分解活性の濃度を決定するための診断試験 |
| EP1400589B1 (de) | 2002-09-18 | 2006-08-09 | SIRS-Lab GmbH | Verfahren zum Nachweis prokaryontischer DNA |
| SI1654387T1 (sl) * | 2003-08-15 | 2009-10-31 | Univ South Florida | Materiali in postopki za ujetje patogenov in odstranitev avrintrikarboksilne kisline iz vzorca |
| US20050065454A1 (en) * | 2003-09-22 | 2005-03-24 | Becton, Dickinson And Company | Non-evacuated blood collection tube |
| US7399609B2 (en) * | 2003-12-30 | 2008-07-15 | 3M Innovative Properties Company | Staphylococcus detection |
| US8419722B2 (en) * | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
| DE102005009479A1 (de) | 2005-03-02 | 2006-09-07 | Molzym Gmbh & Co. Kg | Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden |
| US20100009409A1 (en) * | 2005-07-29 | 2010-01-14 | Ecole Polytechnique Federale De Lausanne | Molecular variant fibrinogen fusion proteins |
| US20080299587A1 (en) * | 2007-05-03 | 2008-12-04 | Dennis Durbin | Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists |
| CA2693565C (en) | 2007-08-02 | 2015-05-26 | Universite Laval | Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids |
| JP5029217B2 (ja) * | 2007-08-27 | 2012-09-19 | 東レ株式会社 | シート状物の製造方法 |
| ES2585246T3 (es) * | 2008-07-09 | 2016-10-04 | Profibrix Bv | Fibrinógeno recombinante |
| CA2768485C (en) | 2009-07-16 | 2018-12-04 | Timothy Foster | Treatment of staphylococci infections using recombinant fibrinogen binding protein clumping factor a |
| US9689881B2 (en) | 2010-09-15 | 2017-06-27 | Spinomix S.A. | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
-
2011
- 2011-09-15 US US13/822,209 patent/US9689881B2/en active Active
- 2011-09-15 CA CA2811493A patent/CA2811493C/en active Active
- 2011-09-15 EP EP11788227.4A patent/EP2616550B1/en active Active
- 2011-09-15 AU AU2011303467A patent/AU2011303467C1/en active Active
- 2011-09-15 DK DK11788227.4T patent/DK2616550T3/en active
- 2011-09-15 CN CN201710338814.XA patent/CN107389932B/zh active Active
- 2011-09-15 JP JP2013528815A patent/JP5999776B2/ja active Active
- 2011-09-15 KR KR1020137009329A patent/KR101948944B1/ko active Active
- 2011-09-15 LT LT16154770T patent/LT3067431T/lt unknown
- 2011-09-15 DK DK16154770.8T patent/DK3067431T3/da active
- 2011-09-15 HU HUE11788227A patent/HUE028915T2/en unknown
- 2011-09-15 CN CN201180044211.XA patent/CN103108959B/zh active Active
- 2011-09-15 ES ES16154770T patent/ES2751660T3/es active Active
- 2011-09-15 PL PL11788227T patent/PL2616550T3/pl unknown
- 2011-09-15 PL PL16154770T patent/PL3067431T3/pl unknown
- 2011-09-15 SI SI201131797T patent/SI3067431T1/sl unknown
- 2011-09-15 EP EP16154770.8A patent/EP3067431B1/en active Active
- 2011-09-15 ES ES11788227T patent/ES2571127T3/es active Active
- 2011-09-15 HU HUE16154770A patent/HUE045771T2/hu unknown
- 2011-09-15 PT PT161547708T patent/PT3067431T/pt unknown
- 2011-09-15 WO PCT/IB2011/054035 patent/WO2012035508A2/en not_active Ceased
-
2016
- 2016-12-02 AU AU2016266066A patent/AU2016266066B2/en active Active
-
2017
- 2017-05-22 US US15/601,677 patent/US20170336424A1/en not_active Abandoned
-
2019
- 2019-10-02 HR HRP20191785TT patent/HRP20191785T1/hr unknown
- 2019-10-11 CY CY20191101074T patent/CY1122166T1/el unknown
-
2021
- 2021-01-28 US US17/160,814 patent/US20210148940A1/en not_active Abandoned
-
2023
- 2023-08-09 US US18/231,880 patent/US20240280593A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013538355A5 (enExample) | ||
| WO2012035508A4 (en) | Method for separating target molecules or particles from fibrinogen-containing samples including blood components | |
| ES2658105T3 (es) | Procedimiento para el enriquecimiento y aislamiento de biomoléculas o virus | |
| AU2004269340B2 (en) | Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample | |
| AU2018203078A1 (en) | Substrates and methods for collection, stabilization and elution of biomolecules | |
| CN110997933B (zh) | 用于稳定无细胞核酸和细胞的方法和组合物 | |
| KR101512709B1 (ko) | 핵산 시료의 제조 방법, 및, 그것을 사용한 핵산 증폭물의 제조 방법 | |
| ES2740838T3 (es) | Dispositivo de recolección y procesamiento de muestras | |
| US20170335312A1 (en) | Method for enriching microvesicles | |
| CN101300487B (zh) | 膜测定方法 | |
| HK1247280B (zh) | 用於从含纤维蛋白原的样品中分离目标分子或颗粒的方法 | |
| WO2012088412A2 (en) | Capture and enrichment of organisms and cells from liquids | |
| WO2025154315A1 (ja) | 微生物捕集試薬、微生物捕集キット、微生物捕集方法、および微生物捕集装置 | |
| AU2012216623B2 (en) | Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample | |
| HK1136317A1 (en) | Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample | |
| HK1136317B (en) | Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample |